Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
May 18, 2026 04:00PM
May 18, 2026 04:00PM
May 7, 2026 07:00AM
Apr 1, 2026 05:12PM
Apr 1, 2026 05:12PM Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Mar 25, 2026 11:48AM
Mar 25, 2026 07:00AM
Mar 25, 2026 07:00AM
Mar 3, 2026 07:21AM
Feb 26, 2026 05:52AM
Feb 24, 2026 11:49AM
Feb 24, 2026 07:01AM Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
Jan 21, 2026 07:44AM
Jan 15, 2026 06:43AM
Jan 12, 2026 07:25AM
Jan 12, 2026 04:04AM
Jan 11, 2026 05:00PM
Dec 9, 2025 11:57AM
Nov 4, 2025 07:00AM Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
Oct 31, 2025 09:54AM
Aug 30, 2025 04:00PM
Aug 14, 2025 07:00AM
Aug 14, 2025 07:00AM
Aug 5, 2025 07:00AM
Jun 3, 2025 07:00AM
Jun 3, 2025 07:00AM Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
May 29, 2025 04:02PM
May 29, 2025 04:01PM
May 12, 2025 04:05PM
May 12, 2025 04:01PM
May 6, 2025 07:00AM
Apr 10, 2025 05:32AM
Apr 5, 2025 07:00AM Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
Mar 27, 2025 04:01PM
Mar 27, 2025 04:01PM
Mar 10, 2025 12:59PM
Mar 10, 2025 12:58PM
Jan 13, 2025 07:04AM
Jan 13, 2025 07:00AM
Jan 6, 2025 02:00PM 7 top biotech picks for 2025 according to Wells Fargo
Nov 5, 2024 09:00AM
Nov 5, 2024 06:30AM
Aug 6, 2024 06:30AM
Nov 8, 2023 06:30AM
Oct 25, 2023 06:30AM
Oct 25, 2023 06:30AM
Jan 9, 2023 06:35AM Beam Therapeutics (BEAM) Reports Progress Across Base Editing Portfolio, Outlines 2023 Milestones
Jan 9, 2023 06:30AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All